1. Home
  2. AIV vs NTLA Comparison

AIV vs NTLA Comparison

Compare AIV & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIV
  • NTLA
  • Stock Information
  • Founded
  • AIV 1975
  • NTLA 2014
  • Country
  • AIV United States
  • NTLA United States
  • Employees
  • AIV N/A
  • NTLA N/A
  • Industry
  • AIV Real Estate Investment Trusts
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AIV Real Estate
  • NTLA Health Care
  • Exchange
  • AIV Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • AIV 1.2B
  • NTLA 1.2B
  • IPO Year
  • AIV 1994
  • NTLA 2016
  • Fundamental
  • Price
  • AIV $7.80
  • NTLA $12.41
  • Analyst Decision
  • AIV Buy
  • NTLA Buy
  • Analyst Count
  • AIV 1
  • NTLA 20
  • Target Price
  • AIV $10.00
  • NTLA $32.30
  • AVG Volume (30 Days)
  • AIV 1.6M
  • NTLA 4.2M
  • Earning Date
  • AIV 11-06-2025
  • NTLA 11-06-2025
  • Dividend Yield
  • AIV 36.19%
  • NTLA N/A
  • EPS Growth
  • AIV N/A
  • NTLA N/A
  • EPS
  • AIV N/A
  • NTLA N/A
  • Revenue
  • AIV $212,439,000.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • AIV $6.96
  • NTLA $8.32
  • Revenue Next Year
  • AIV N/A
  • NTLA N/A
  • P/E Ratio
  • AIV N/A
  • NTLA N/A
  • Revenue Growth
  • AIV 7.07
  • NTLA 14.99
  • 52 Week Low
  • AIV $6.89
  • NTLA $5.90
  • 52 Week High
  • AIV $9.42
  • NTLA $23.76
  • Technical
  • Relative Strength Index (RSI)
  • AIV 49.26
  • NTLA 62.53
  • Support Level
  • AIV $7.40
  • NTLA $10.89
  • Resistance Level
  • AIV $7.98
  • NTLA $12.03
  • Average True Range (ATR)
  • AIV 0.16
  • NTLA 0.73
  • MACD
  • AIV 0.03
  • NTLA 0.09
  • Stochastic Oscillator
  • AIV 68.10
  • NTLA 68.85

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: